Little Da Vincis: Interview with Dr. Anand Srivastava
The massive fervor around blockchain technology has quelled a bit due to a number of challenges facing the emerging industry ranging from speed and cost to interoperability and perception. The fact that many, more vocal blockchain devotees are working a bit more quietly through such issues now gives the chance for others to start to come to surface. Many innovators are finding new ways to apply blockchain technology and in a manner beyond solely that of the financial and advertising realms, for example. In fact when coupled with a philanthropic intent, blockchain seems now poised to reach even greater heights because the work is fused with true social benefit.
Indeed a GIOSTAR Labs, a company which is focused on stem cell-based technologies and is a subsidiary of a company called Giostar, recently joined forces with the Association of Professional Ball Players of America (APBPA) to launch what the company is calling the non-profit Stem Cells For All initiative. The intent is to provide, for the first time ever, stem cell treatment to athletes, families, fans at deep discounts, and GIOSTAR will will be one of the first to apply blockchain in a new way to ensure successful outcome.
This work is the brainchild of GIOSTAR Chairman and Co-founder Dr. Anand Srivastava. Who, along with his fellow co-founder and team realized the fact that many baseball players face injuries which require not only extensive surgery that is demanding on the body but that which can also causes severe financial stress as well. So they decided to create a pilot initiative where members of the APBPA can now receive free or deeply discounted therapies at GIOSTAR’s Chicago location, the office dedicated solely to providing stem cell services to the underserved.
But it is blockchain technology which will up the ante in the treatment process. Explains GIOSTAR Co-Founder Siddarth Bhavsar, “Federated permissioned blockchain based on HIPAA compatible nodes allows us to build trust via data integrity and permissioned collaboration from the ground up.” He continues, “Since personalized precision medicine like stem cells entails an additional level of data complexity, thus an AI and NLP algorithms layer will bring greater structure and extract meaning from the data to improve accuracy.”
So far, six pitchers have undergone therapy with additional procedures underway thanks to generous donations and successful fundraisers. These athletes include Arnie Costell of the Houston Astros and the Detroit Tigers and Mike Rossiter of the Oakland Athletics and Milwaukee Brewers.
Now GIOSTAR says that dozens of subsidized therapies are underway as a result of their agreement with the Association. The lab will be working to release cutting edge technology in stem cell application with blockchain integration over the next 12 months enabling enabling them to decrease therapy costs, disrupt the pricing model of the industry and allow them to treat more people than the industry ever has.
GIOSTAR says that it intends to engage the Food and Drug Administration (FDA) via the Regenerative Medicine Advanced Therapy (RMAT) process to ensure proper safety protocols and efficacy and plans to commercialize stem cell therapy as a service by launching a suite of shippable, stem cell-derived growth factor products.
Regenerative medicine has been called the next evolution of medical treatments by the U.S. Department of Health and Human Services, however the field is not without controversy and confusion about what is and is not possible in terms of cures within this emerging space. Many professionals in the arena say that the results are simply not as straightforward as purported. In fact, Consumer Reports printed an extensive investigative piece not long ago on the industry, though much of this pushback was tied to high costs for the services.
Bhavsar is undaunted and fiercely driven precisely because of the cost-disruption model. He explains, “Just as open-source software model drove exponential innovation in the technology sector, we believe open-source clinical research model powered by blockchain and AI will improve efficiency, accuracy, reduce costs and accelerate innovation in healthcare.”
Though based in San-Diego, GIOSTAR now has similar plans for such initiatives in India, China and Mexico. Dr. Srivastava already has deep ties to India through his previous invitation from the country’s Ministry of Human Resources Development to train scientists in the region in the field of advanced stem cell science.
Says Bhavsar, “Each day we are moving one step closer to fulfilling our mission to make this amazing science accessible and affordable to the masses thanks to emerging technology and major dedication.”
“The intent is to provide, for the first time ever, stem cell treatment to athletes, families, fans at deep discounts, and GIOSTAR will be one of the first to apply blockchain in a new way to ensure successful outcome.”
Chairman and Co-Founder of GIOSTAR Dr. Anand Srivastava was invited by Ministry of Human Resources Development, Government of India to train Indian scientists in the field of advanced stem cell science.
The program was conducted by Department of Life Sciences, University of Calicut, Kerala under name of GIAN. He trained and shared his experience of stem cells research with scientist/researchers for ten days.
Dear Dr. Anand S Srivastava,
I’m writing to follow-up my last invitation as below, would you please give me a tentative reply? Thank you very much. I apologize for the inconvenience if the letter disturbed you more than once.
With the theme of “Decoding Life Secrets, Boosting Industrial Development”, the BIT’s 10th World Gene Convention-2019 (WGC-2019) will be held during September 20-22, 2019 in Qingdao, China, On behalf of the organizing committees of WGC-2019, we would be honor to welcome you to be a chair/speaker under Session 5-7: Stem Cell, Tissue Engineering and Regeneration regarding on Stem Cell, Tissue Engineering and Regeneration….. We sincerely wish you can accept our suggestion and join us in Qingdao, China!
WGC had been successfully organized in Singapore, Macau, Shanghai, Qingdao and Haikou in last nine years. During previous conference, more than 300 speakers and 30+ poster attendees had presented their up-to-date research and made a fulfill communication on timely issues in the field of Gene each year. With the kindly praise and suggestions from our participants, we believe WGC-2019 will be the perfect opportunity and platform to establish a high profile international communication both in academic research and business activities.
The three-day conference comprises 6 Professional programs, mainly focused on: breakthroughs in gene, advances genomics & genetics, new research of DNA and RNA, focus on basic research, the frontier research of life sciences, new biotherapy discovery, emerging areas for medicine applications, robust technology development, and cutting-edge Biotechnology. It aims to provide a platform for all experts from academia, industry and national labs to discuss latest hot researches and achievements. Attendees will hear world-class speakers discussing the challenges and opportunities facing the gene, biotechnology and life sciences field. The business & academic experts who are from home and abroad will give excellent speeches.
We expect your precious comments or suggestions; also your reference to other speakers will be highly appreciated. We look forward to receiving your replies on the following questions:
For more information, please visit the conference website http://www.bitcongress.com/wgc2019/
In addition to the amazing conference, you will benefit from the wonderful experience in Qingdao, China. Qingdao (Tsingtao) is a city of picturesque red-tiled roofs nestled between green hills and blue sea. The mild climate, the bathing beach, and Mount Laoshan make Qingdao a popular health and holiday resort, particularly in summer when visitors come here in droves for sightseeing and escaping the heat.
We sincerely hope that you will contribute your invaluable experience and knowledge at this magnificent Congress in 2019, and enjoy yourself in Qingdao, China! Look forward to hearing from you soon!
Ms. Teresa Xiao
The Patient was suffering for 5 years and tried all conventional medicine available for Eczema in the market. Only one Stem Cell Treatment has cleared the skin from the disease.